Tyldesley S, Roques T W, Erridge S
Department of Radiation Oncology, Vancouver Cancer Clinic, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
Lung Cancer. 2007 Sep;57(3):381-8. doi: 10.1016/j.lungcan.2007.03.024. Epub 2007 May 7.
Stage, weight loss, and performance status (PS) are important prognostic factors and eligibility factors for curative intent therapy for lung cancer patients. Details of stage, weight loss, and PS are often not collected until referral to a cancer specialist, and since not all patients are referred to cancer specialists these important variables are not well defined at a population level.
Data on stage, weight loss, PS and referral pattern were requested from general practitioners (GPs) on all lung cancer patients diagnosed between May and June of 2002 in the province of British Columbia, Canada. Outcomes were analyzed in relation to survival and referral to a cancer centre.
395 patients were identified, and GP questionnaires were returned on 85% of the cases. Patients referred to a cancer centre shortly after diagnosis differed from those who were not referred. Patients who were not referred to a cancer centre consisted of two groups-patients with localized disease and good PS who tended to have a better survival than those who were referred, and patients with advanced disease and poor performance status who tended to have a worse survival than those who were referred. GP assessed stage and PS are prognostic factors for survival.
GP assessed stage and PS are prognostic factors for survival in lung cancer patients. The case mix of patients who are not referred to a cancer centre shortly after their diagnosis differs from those that are referred.
分期、体重减轻和体能状态(PS)是肺癌患者根治性治疗的重要预后因素和入选标准。分期、体重减轻和PS的详细信息通常直到患者转诊至癌症专科医生时才会收集,而且由于并非所有患者都会转诊至癌症专科医生,这些重要变量在人群层面并未得到很好的界定。
向加拿大不列颠哥伦比亚省2002年5月至6月间确诊的所有肺癌患者的全科医生(GP)索要有关分期、体重减轻、PS及转诊模式的数据。分析了与生存及转诊至癌症中心相关的结果。
共识别出395例患者,85%的病例返回了GP调查问卷。诊断后不久转诊至癌症中心的患者与未转诊患者有所不同。未转诊至癌症中心的患者包括两组——疾病局限且PS良好的患者,其生存往往优于转诊患者;以及疾病晚期且体能状态差的患者,其生存往往比转诊患者更差。GP评估的分期和PS是生存的预后因素。
GP评估的分期和PS是肺癌患者生存的预后因素。诊断后不久未转诊至癌症中心的患者病例组合与转诊患者不同。